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Abstract 
This paper represents an updating 
of a previous manuscript. It summarizes 
the author's experience and brings the 
material up to 90% plus follow-up, still 
with no pregnancies in patients who 
met the criteria of the successful treat- 
ment plan. 
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Introduction 
This paper is an updating of "Postcoital Contraception with 
Diethylstilbestrol", published October, 1971 (1). In April, 1971, 
with the completion of the follow-up of 1000 females of child 
bearing age at the University of Michigan Health Service who met 
the criteria of one unprotected or inadequately protected sexual 
exposure since their last normal menstrual period, came in for 
treatment within 72 hours of exposure and who completed the 
medical treatment of 25 mg of stilbestrol, twice daily for five 
days, there were no pregnancies. However, there were 1410 women 
who received this therapy from the fall of 1967 through April, 
1971, the cut-off time for the study. In patient interest and 
for scientific validity, it was important to make an effort to 
complete the follow-up of the women who had not been contacted. 
Methods 
An inquiry form was filled out at the time of the first visit, 
on which was recorded the patient's name, address, phone number, 
age, last menstrual period, usual cycle, hours between exposure 
and taking DES, any other unprotected exposures since last menses, 
prophylaxis, contraindications to estrogen therapy, and the 
amount of medication and directions for taking. It was explained 
to the patient that stilbestrol was not a new drug but this 
was a new use and a follow-up was expected. The possibility 
of failure was explained, and it was only given to consenting 
women. Possible side reactions to estrogen were discussed. Also, 
it was emphasized that this was an emergency type of treatment, 
and should a continuing need for contraception exist, other 
means should be sought. A return visit was requested after 
their next menses, or sooner if they were having any problem. 
At that time they were questioned as to the character of the 
menses, any side reactions, a physical examination done if indi- 
cated, and counseling offered. This information was also recorded 
on the inquiry form. Actually by the time a number of the 
patients were contacted, two or more menses had occurred. 
The Health Service Pharmacy was very helpful by recording a 
copy of each prescr.iption number and patient name, on a separate 
record. Thus, one could check the returned inquiry forms from 
the physicians with the prescription numbers and names, and if 
a form was lacking, the medical record was pulled to see if the 
patient had returned as requested, and the information was 
there. If not, the patient was contacted. The women filled 
this type of prescription virtually 100% at the Health Service 
Pharmacy or Health Service Emergency Room. 
JULY 1974 VOL. 10 NO. 1 
CONTRACEPTION 
This therapy was carried out under the direction of Jan 
Schneider, Associate Professor of Obstetrics and Gynecology, 
from the University of Michigan Medical Center. 
Results 
Of the 1410 patients, completed data was obtained on 1298 
by July, 1972. In spite of great efforts on the author's part, 
112 women could not be reached as they had moved, married, etc. 
Efforts to reach this group were discontinued in July, 1972. 
Of the 1298 patients contacted, 1217 met the criteria of 
the 1000 stated earlier in this paper, and there were no preg- 
nancies. 
There were 81 women who did not meet the criteria for 
various reasom,such as: different medication dose schedules, 
coming in later than 72 hours after exposure, multiple exposures 
without treatment since last normal period then finally coming 
in, and there were some who did not complete the medication as 
prescribed. There was a 100% follow-up of this group of 81; 
probably because most of these cases were seen in the early 
part of the study. There were six pregnancies in this group of 
81. They had each had sexual relations at other times since 
their last normal period without coming in for treatment, and 
two of the six, in addition to multiple exposures, came in over 
72 hours after the last unprotected sexual relations to.get 
treatment. Each of the six chose to terminate the pregnancy by 
abortion. 
Tables are presented showing data on the 1217 who met the 
previously stated criteria. When the word, DNRNOWN, is listed, 
this means the patient did not note the information in her 
correspondence or the physician did not record it on the inquiry 
form. 
Table I shows the time of exposure in relation to the menstrual 
cycle and the expected time of ovulation. 
Table II shows the per cent not using contraception, plus 
those using some, and the methods used. 
Table III shows the incidence of side reactions. One might 
note that 45% had virtually none. Although the medication was 
usually prescribed one tablet after breakfast and one after the 
evening meal to decrease possible gastric irritation, the nausea, 
if it occurred, did so usually about six to eight hours after 
ingestion of the DES tablet. This was interpreted as a systemic 
reaction to estrogen. The various antiemetics available seemed 
helpful at times if indicated. 
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TABLE I 
TIME OF EXPOSURE IN RELATION TO THE MENSTRUAL CYCLE 
No. of patients Percent 
*Midcycle 849 69.76 
Not midcycle 224 18.41 
Irregular 75 6.16 
Recently discontinued oral contraception 12 0.99 
Post-abortion and before first menses 
after abortion 4 0.33 
Unknown 53 4.35 
*Midcycle includes exposures to sexual intercourse 3 days before 
or 3 days after expected time of ovulation. 
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TABLE II 
USE OF PROPHYLAXIS 
*None 
No. of patients 
1089 
Coitus interruptus 66 
Condom alone 17 
Contraceptive foam or jelly alone 20 
Ejaculation on external genitalia 9 
Birth control pills forgotten several 
days or had been on them the first 
time for only 2-3 days 4 
Miscellaneous as tampon, douche after 
intercourse, condom and foam but 
use preceeded by foreplay, diaphram 











Huhner tests were not done on any of the above patients. 
*None includes cases where condom came off intravaginally or condom 
broke intravaginally. 
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TABLE III 
SIDE REACTIONS TO DIETHYLSTILBESTROL 
*None 
Nausea, slight, hardly noticeable 
Nausea without vomiting 
Nausea and vomiting, intermittent 1 day 
Nausea and vomiting, intermittent more than 
1 day 
Headache 




Bloated or swollen condition 
Miscellaneous as breast tenderness, increased 
vaginal secretions, mild lower abdominal 
cramps, etc. 
Unknown 

















Note: As some patients had more than one side reaction, the total 
number of side reactions was 1261 in the 1217 patients. 
*Includes 43 patients with only tired feeling. 
Table IV describes the character of the first menses after 
the therapy, and it is particularly important to emphasize that 
about 12% had late periods. Should delayed menses occur, the 
patient's knowledge of this possibility reduces unnecessary anxiety. 
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TABLE IV 
CHARACTER OF FIRST MENSES FOLLOWING THE COURSE OF STILBESTROL 
Normal time and flow 
No. of patients Percent 
543 44.62 
Normal time and lighter flow 81 6.66 
Normal time and heavier flow 30 2.47 
Early onset (usually few days only) 67 5.50 
Late onset (l-7 days) 75 6.16 
Late onset (more than 7 days) 71 5.83 
Irregular 45 3.70 
Unknown 305 25.06 
Discussion 
To evaluate the benefit of treatment, one wants to know 'what 
the incidence of pregnancy with one unprotected exposure-would 
have been with about 70% of the patients coming in at the expected 
time of ovulation. Udry of the University of North Carolina at 
Chapel Hill, applying the work of his colleagues there on fertility 
and timing, especially that of Lachenbruch, indicated to Family 
Planning Digest that the risk of pregnancy from a single coital 
act has been estimated for each part of the menstrual cycle. 
On the basis of these calculations, he believes that the overall 
premeditation risk among Dr. Kuchera's patients was about one 
in ten, making 100 probable pregnancies a 'reasonable estimate' (2). 
His evaluation was done on the initial 1000 patients. 
Morris and van Wagenen, at Yale, published a paper on this 
type of therapy and arrived at a pregnancy rate of 0.03% (3). 
They have done the pioneering work on this type of therapy for 
humans in this country (4). 
There appears to be no serious side effects to the women 
receiving DES for postcoital contraception. However, long term 
effects to the baby, in the event of failure, and in the absence 
of abortion, are unknown. Because it is known that normally 2-6% 
of all children born have congenital defects, and because there 
is a definite link between carcinoma of the genital tract in 
the female offspring of women who received stilbestrol while 
pregnant, should the morning-after pill fail, the mother should 
be offered the choice of an abortion. 
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Comments 
Points to emphasize when prescribing this therapy: 
1. It is very important to establish by whatever means necessary, 
that the patient desiring the treatment is NOT pregnant, as stil- 
bestrol is CONTRA-INDICATED in pregnancy. 
2. Possible side reactions to the medication should be discussed. 
3. The patient should be advised that this will not bring on a period. 
4. She should be told she is not protected against pregnancy in 
further sexual relations while on the medication, and should this 
be desired, she should use adequate contraceptive protection. 
5. Repeated use should be discouraged. When it was explained to 
the patient that there is as much estrogenic activity in these 
10 tablets of stilbestrol totalling 250 mg as in a ten month supply 
of some of the oral contraceptives currently used, this seemed 
to be quite an effective deterrent. 
6. Stress the emergency nature of this treatment, and should a 
continuing need for pregnancy prevention exist, other contraceptive 
means should be used. 
7. Offer counseling, as many times this is a first time experience 
for the patient. 
Summary 
This paper represents an updating of a study done at the 
University of Michigan Health Service from the fall of 1967 through 
April, 1971. Of the 1410 women of child bearing age who received 
the morning-after pill, diethylstilbestrol, 1298 have received 
follow-up, or a total of 92.1%. Of the 1217 patients who met the 
criteria of having had one unprotected or inadequately protected 
sexual exposure since the last normal menstrual period, who came 
in for therapy within 72 hours of the fact, and completed the 
course of 25 mg of DES twice daily for five days, there were no 
pregnancies, or 100% effectiveness. One would have to conclude, 
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